Medical University Innsbruck
Also known as: Department for Neurology, Medical University Innsbruck | Department of Anesthesia and Intensive Care | Department of Biological Psychiatry, Innsbruck University Clinics | Department of Trauma Surgery, Medical University of Innsbruck, Austria | Dr. Claudia Bösmüller | Dr. Gerhard Pölzl | General and Surgical Intensive Care Medicine, Medical University Innsbruck | Georg.Pall@i-med.ac.at | Innsbruck Medical University | Innsbruck Medical University, Dep. for Anaesthesia and Crit. Care Management | Innsbruck Medical University, Innsbruck, Austria | Medical University for Surgery and Transplantation, Innsbruck | Medical University Innsbruck | Medical University Innsbruck, Departement of Anaesthesiology and Intensive Care | Medical University Innsbruck, Department of Internal Medicine I | Medical University Innsbruck, Department of Neurology, Innsbruck 6020, Austria | Medical University of Innsbruck | Medical University of Innsbruck, Deparmtment of Internal Medicince I | Medical University of Innsbruck, Department of Anesthesiology and Intensive Care Medicine | Medizinische Universitaet Innsbruck | MUI, Department of Anaesthesiology and Critical Care Medicine | Universitätsklinik Innsbruck, Universitätsklinik für Neurochirurgie | University Hospital for Neurosurgery Innsbruck | University Hospital for Visceral, Transplant and Thoracic Surgery | University Hospital Innsbruck, Austria | University Hospital Innsbruck, Dept. of General- and Transplant Surgery, Anichstrasse 35, A-6020 Innsbruck | University Hospital Innsbruck, Internal Medicine | University of Innsbruck | University of Innsbruck / Department of Mechatronics | Volker Wenzel | Wolfgang-Michael Franz
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2004Last known activity
Aug 1, 2025
Timeline
2000s
- Jan 1, 2004
Medical University Innsbruck— Founded
Drugs by trial phase (87 distinct, 66 trials)
Phase 4 (19 own, 0 via acquisition)
Phase 3 (30 own, 0 via acquisition)
Phase 2 (29 own, 0 via acquisition)
Phase 1 (5 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Acute Kidney Injury
- Aneurysm
- Arthritis
- Arthritis, Psoriatic
- Atrophy
- Blood Coagulation Disorders
- Brain Diseases
- Brain Injuries
- Brain Injuries, Traumatic
- Brain Ischemia
- Bunion
- Carcinoma
- Carcinoma in Situ
- Carcinoma, Neuroendocrine
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Cervical Intraepithelial Neoplasia
- Colorectal Neoplasms
- Coronavirus Infections
- Critical Illness
- Diabetes Mellitus, Type 1
- Diabetic Foot
- Endometrial Neoplasms
- Esophageal Neoplasms
- Fallopian Tube Neoplasms
- Gastrointestinal Stromal Tumors
- Glioblastoma
- Glioma
- Hallux Valgus
- Head and Neck Neoplasms
- Heart Failure
- Hemangiosarcoma
- Hemorrhage
- Hemostatic Disorders
- Hypovolemia
- Hypoxia
- Hypoxia-Ischemia, Brain
- Inflammation
- Intervertebral Disc Degeneration
- Intervertebral Disc Displacement
- Ischemia
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Macular Degeneration
- Mastodynia
- Multiple System Atrophy
- Myelodysplastic Syndromes
- Neoplasms
- Neurodegenerative Diseases
- Opioid-Related Disorders
- Ovarian Neoplasms
- Papillomavirus Infections
- Parkinson Disease
- Peritoneal Neoplasms
- Preleukemia
- Proctitis
- Schizophrenia
- Shock
- Shock, Hemorrhagic
- Shy-Drager Syndrome
- Squamous Cell Carcinoma of Head and Neck
- Subarachnoid Hemorrhage
- Substance-Related Disorders
- Syndrome
- Thrombosis
- Thyroid Diseases
- Thyroid Neoplasms
- Tobacco Use Disorder
- Uterine Cervical Neoplasms
- Wounds and Injuries
Recent trials (50)
- NCT07044336OfficialPhase 3Aug 1, 2025
- NCT06852612CollaboratorN/AApr 24, 2025
- NCT06582329Lead sponsorPhase 2Jan 31, 2025
- NCT05946707OfficialN/AJul 19, 2023
- NCT05946707Lead sponsorN/AJul 19, 2023
- NCT05871320CollaboratorEarly Phase 1Dec 23, 2022
- NCT06327841OfficialN/AJun 21, 2022
- NCT06327841Sponsor investigatorN/AJun 21, 2022
- NCT06327841Lead sponsorN/AJun 21, 2022
- NCT07060053Lead sponsorN/AMay 4, 2022
- NCT07060053Sponsor investigatorN/AMay 4, 2022
- NCT04875585Reponsible party - principal investigatorPhase 2Sep 30, 2021
- NCT04875585Overall official - principal investigatorPhase 2Sep 30, 2021
- NCT04875585Lead sponsorPhase 2Sep 30, 2021
- NCT04924257Lead sponsorPhase 3Aug 31, 2021
Details
- Founded
- Innsbruck, AT Jan 1, 2004
- Last known activity
- Aug 1, 2025